Kavya Deshpande
Stock Analyst at UBS
(1.26)
# 3,624
Out of 4,579 analysts
49
Total ratings
56%
Success rate
-1.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kavya Deshpande
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: SOON Sonova Holding AG | Upgraded: Buy | CHF 242.00 | CHF 218.00 | +11.01% | 1 | Jul 22, 2026 | |
| ETR: SHL Siemens Healthineers AG | Maintained: Hold | €38.00 | €35.56 | +6.86% | 1 | Jul 14, 2026 | |
| EPA: BIM bioMérieux S.A. | Downgraded: Hold | €138.00 → €80.00 | €70.70 | +13.15% | 12 | Jun 1, 2026 | |
| WILLF Demant A/S | Reiterated: Buy | $42 | $41.51 | +0.40% | 1 | May 21, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Downgraded: Hold | €84.00 → €66.00 | €67.08 | -1.61% | 17 | Apr 9, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Hold | kr 34.00 → kr 30.00 | kr 34.10 | -12.02% | 16 | Feb 17, 2026 | |
| STO: EKTA.B Elekta AB (publ) | Initiated Coverage: Sell | kr 34.00 | kr 48.44 | -29.81% | 1 | Sep 3, 2025 |
Sonova Holding AG
Jul 22, 2026
Upgraded: Buy
Price Target: CHF 242.00
Current: CHF 218.00
Upside: +11.01%
Siemens Healthineers AG
Jul 14, 2026
Maintained: Hold
Price Target: €38.00
Current: €35.56
Upside: +6.86%
bioMérieux S.A.
Jun 1, 2026
Downgraded: Hold
Price Target: €138.00 → €80.00
Current: €70.70
Upside: +13.15%
Demant A/S
May 21, 2026
Reiterated: Buy
Price Target: $42
Current: $41.51
Upside: +0.40%
DiaSorin S.p.A.
Apr 9, 2026
Downgraded: Hold
Price Target: €84.00 → €66.00
Current: €67.08
Upside: -1.61%
Vimian Group AB (publ)
Feb 17, 2026
Maintained: Hold
Price Target: kr 34.00 → kr 30.00
Current: kr 34.10
Upside: -12.02%
Elekta AB (publ)
Sep 3, 2025
Initiated Coverage: Sell
Price Target: kr 34.00
Current: kr 48.44
Upside: -29.81%